Diversiteit en psychiatrie
De Koning, M.B., Dom, G., Duvivier, R., Muller, D.P., Özgen, M.H., Rhebergen, D. &
Van, H.Verschenen in Tijdschrift voor psychiatrie , 64, 485-486 (2022)
The effectiveness of intensive home treatment as a substitute for hospital admission in acute psychiatric crisis resolution in the Netherlands: a two-centre Zelen double-consent randomised controlled trial
Cornelis, J.,
Barakat, A.,
Blankers, M.,
Peen, J.,
Lommerse, N.M., Eikelenboom, M.,
Zoeteman, J.,
Van, H.,
Beekman, A.T.F. &
Dekker, J.J.M.Verschenen in The Lancet Psychiatry (2022)
Deinstitutionalization from the perspective of community-dwelling adults with a severe mental illness in Amsterdam: a cohort study protocol
Segeren, M., Lauriks, S.,
Kikkert, M.J., Heering, J.,
Lommerse, N.M., van Husen, G. & Verhoeff, A.
Verschenen in BMC Public Health, 22 (2022)
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorder
Okhuijsen-Pfeifer, C., van der Horst, M.Z., Bousman, C.A., Lin, B., van Eijk, K.R., Ripke, S., Ayhan, Y., Jeger-Land, E.,
De Koning, M.B., GROUP investigators & Luykx, J. (et al.)
Verschenen in Translational Psychiatry, 12, 145 (2022)
Oxidative stress in psychosis: a new target for intervention?
Hagen, J., Sutterland, A.L., Wezenberg, B.N., Tan, H.L. &
De Haan, L.Verschenen in Tijdschrift Voor Psychiatrie, 64 (1), 38-42 (2022)
De ondervertegenwoordiging van complexe patiëntengroepen in wetenschappelijk onderzoek: ethische overwegingen
De Koning, M.B.,
Burger, T.,
Van Eck, R.,
Kikkert, M.J.,
De Haan, L. &
Vellinga, A.Verschenen in Tijdschrift voor Psychiatrie, 63, 731-736 (2021)
Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach
de Nijs, J.,
Burger, T., Janssen, R.J., Mostafa Kia, S., van Opstal, D.P.J.,
De Koning, M.B.,
De Haan, L., GROUP Investigators, Cahn, W. & Schnack, H.G.
Verschenen in Nature: Schizophrenia (2021)
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Begemann, M.J.H., Thompson, I.A., Veling, W., Gangadin, S.S., Geraets, C.N.W., van 't Hag, E., Müller-Kuperus, S.J., Oomen, P.P., Voppel, A.E., van der Gaag, M.,
Kikkert, M.J., van Os, J., HAMLETT Group,
De Haan, L. & Sommer, I.E.C.
Verschenen in Trials, 21, 147 (2021)
Tapering antipsychotic medication: practical considerations
Horowitz, A., Moncrieff, J.,
De Haan, L., Bogers, J.P.A.M., Gangadin, S.S.,
Kikkert, M.J., Veling, W. & Sommer, I.E.C.
Verschenen in Psychological Medicine, 52 (1) (2021)
Ethnic discrimination and depressed mood: The role of autonomic regulation
Hagen, J., Sutterland, A.L., Collard, D., de Jonge, C.D.E., van Zuiden, M., Zantvoord, J.B.,
De Haan, L., Lok, A. & et al.
Verschenen in Journal of Psychiatric Research, 144, 110-117 (2021)
Medication strategies in first episode psychosis patients: A survey among psychiatrists
Kikkert, M.J., Veling, W.,
De Haan, L., Begemann, M.J.H.,
De Koning, M.B., HAMLETT and OPHELIA Consortium & Sommer, I.E.
Verschenen in Early Intervention in Psychiatry, 1-8 (2021)
Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis
Hagen, J., Sutterland, A.L., Liefers, T.,
Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L.O., Zwinderman, A.H. &
De Haan, L.Verschenen in Journal of Affective Disorders, 282, 1082-1089 (2021)
A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder
Lange, S.M.M., Schirmbeck, F., Stek, M.L., Murk Jansen, Y.R., van Rooijen, G.,
De Haan, L., Penninx, B.W.J.H. & Rhebergen, D.
Verschenen in Journal of Psychiatric Research, Volume 135, 143-151 (2021)
An old but still burning problem: Inter-rater reliability in clinical trials with antidepressant medication
Berendsen, S., Verdegaal, L.M.A., van Tricht, M.J.,
Blankers, M.,
Van, H. &
De Haan, L.Verschenen in Journal of Affective Disorders, Volume 276, 748-751 (2020)
Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study
Hagen, J., Sutterland, A.L., da Fonseca Pereira de Sousa, P.A.L.,
Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L., Zwinderman, A.H. &
De Haan, L.Verschenen in Journal of Affective Disorders, 275, 230-237 (2020)
